Amylyx Pharmaceuticals, Inc. (AMLX), a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, is making waves in the biotech industry. Specializing in the discovery and development of treatments for neurodegenerative diseases..
Zenas BioPharma, Inc. (NASDAQ: ZBIO) is garnering attention in the biotechnology sector with a notable potential upside of 86.48%. This clinical-stage biopharmaceutical company, headquartered in Waltham, Massachusetts, is pioneering transformative..
Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage biotechnology company, is generating considerable investor interest with its focus on precision medicines for targeted oncology and genetic diseases. Despite its current challenges,..
Geron Corporation (NASDAQ: GERN), a biopharmaceutical company focused on oncology therapeutics, is currently catching the eye of investors with its remarkable potential upside of 153.5%. Operating out of Foster City,..
Gyre Therapeutics, Inc. (NASDAQ: GYRE) is attracting attention in the investment community with its impressive potential upside of 164.90%, according to recent analyst ratings. Operating in the dynamic biotechnology industry,..
CareDx, Inc. (NASDAQ: CDNA) is a prominent player in the healthcare sector, specializing in diagnostics and research. With a current market capitalization of approximately $665.87 million, the company has carved..
Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology firm specializing in innovative oncolytic immunotherapies, stands at a pivotal moment. With a market capitalization of $437.11 million, Replimune operates within the..
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is capturing the attention of investors with its strong potential upside of 201.97%, as suggested by analyst ratings. As a clinical-stage biotechnology company based..
ArriVent BioPharma, Inc. (NASDAQ: AVBP) is capturing the attention of investors with its intriguing potential in the biotechnology sector, specifically in oncology. As a clinical-stage biopharmaceutical company, ArriVent is focused..
Butterfly Network, Inc. (NYSE: BFLY), a pioneering company in the healthcare sector, operates at the forefront of medical device innovation with its ultrasound imaging solutions. Known for its inventive technology,..
Bicara Therapeutics Inc. (NASDAQ: BCAX) is making waves in the healthcare sector, specifically within the biotechnology industry, with its innovative approach to cancer treatment. Based in Boston, Massachusetts, this clinical-stage..
Valneva SE (VALN), a French biotechnology firm, is carving a niche in the healthcare sector with its focus on developing vaccines for infectious diseases with unmet medical needs. With a..
Castle Biosciences, Inc. (NASDAQ: CSTL), a dynamic player in the healthcare sector, is making waves with its innovative diagnostics and research solutions. Specializing in molecular diagnostics, Castle Biosciences provides crucial..
iRadimed Corporation (NASDAQ: IRMD) has emerged as a noteworthy player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of approximately $897.14 million, this U.S.-based..
Sonida Senior Living, Inc. (SNDA) stands as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of approximately $484.32 million, this..
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, is making waves with its innovative approach to cell programming. Based in Boston, Massachusetts, this company is..
SIGA Technologies Inc. (NASDAQ: SIGA), a key player in the healthcare sector focusing on the specialty drug manufacturing industry, has recently caught the attention of savvy investors. With a market..
AxoGen, Inc. (NASDAQ: AXGN) stands at a compelling intersection of innovation and growth potential within the healthcare sector, particularly in the niche of medical devices for peripheral nerve regeneration and..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is drawing significant attention in the healthcare sector. With a current market capitalization of $1.24 billion, this specialty pharmaceutical company is making waves with its..
